The privately held biotech, which moved from Kentucky to San Antonio in 2014, is preparing to enroll the first patients in a clinical trial to test the safety and efficacy of its Surfacer Inside-Out Access Catheter System. The clinical trial will evaluate the reliability of Bluegrass Vascular's…
News
- Local biotech takes a major step toward US product launch
- From tragedy comes life: Teen honored for organ donation
SAN ANTONIO -- From tragedy comes a legacy of saving lives. A local teenager was honored for donating his organs. ... A biomedical engineering student, Elizondo was eager to find a cure for a chronic illness he himself suffered from. He may not have had time to achieve that dream... but his…
- How one SA teenager saved 5 lives - and how you could too
A biomedical engineering student, Elizondo was eager to find a cure for a chronic illness he himself suffered from. He may not have ... Or, a contribution can be made at Cadence Bank - San Antonio Branch, 10003 NW Military Highway, Suite 3207, San Antonio, TX 78231, (210) 764-5500. To sign up to…
- The hottest thing in cancer drug development is a takeover target again — here's what you need to ...
San Antonio Express-News; San Antonio Boy Attempts Icy Stunt by Jumping on Slick... Storyful; Car ... He's now the executive chairman of Rubius Therapeutics, a biotech firm that's also working with cell therapy to develop treatments like the CAR-Ts that don't have to be as personalized. The hope…
- Technology companies lead US stocks higher in early trading
DEAL TALK: Juno Therapeutics soared 46.5 percent after the Wall Street Journal reported that biotech drugmaker Celgene might buy it. Juno is one of several companies developing therapies that involve genetically engineering patients' blood cells to fight cancer. Shares in Juno rose $21.21 to $66…